Observational studyAddiction (Abingdon, England)2025
Identifying key risk factors for intentional self-harm, including suicide, among a cohort of people prescribed opioid agonist treatment: A predictive modelling study.
Observational study in Addiction (Abingdon, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Self-harm in individuals with substance use disorders: Predictive factors and risk model.Addiction (Abingdon, England) · 2026Article
- Identifying key risk factors for intentional self-harm, including suicide, among a cohort of people prescribed opioid agonist treatment: A predictive modelling study.Addiction (Abingdon, England) · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
BACKGROUND AND
aimsPeople with opioid use disorder are at increased risk of intentional self-harm and suicide. Although risk factors are well known, most tools for identifying individuals at highest risk of these behaviours have limited clinical value. We aimed to develop and internally validate models to predict intentional self-harm and suicide risk among people who have been in opioid agonist treatment (OAT).
designRetrospective observational cohort study using linked administrative data.
settingNew South Wales, Australia.
participants46 330 people prescribed OAT between January 2005 and November 2017. MEASUREMENTS: Intentional self-harm and suicide prediction within a 30-day window using linked population datasets for OAT, hospitalisation, mental health care, incarceration and mortality. Machine learning algorithms, including neural networks and gradient boosting, assessed over 80 factors during the last 3, 6 and 12 months. Feature visualisation using SHapley Additive exPlanations.
findingsGradient boosting identified 30 important factors in predicting self-harm and/or suicide. These included the most recent frequency of emergency department presentations; hospital admissions involving mental disorders such as borderline personality, substance dependence, psychosis and depression/anxiety; and recent release from incarceration. The best fitting model had a Gini coefficient of 0.65 [area under the curve (AUC) = 0.82] and was applied to 2017 data to estimate the probability of self-harm and/or suicide. On average 46 people (0.16%) (from a total of 28 000 people in OAT) experienced intentional self-harm or suicide per month. Applying a 0.15% probability threshold, approximately 5167 people were classified as high risk, identifying 69% of all self-harm or suicide cases per month. This figure reduced to 450 per month after excluding people already identified in the previous month.
conclusionsAmong people in opioid agonist treatment, administrative linked data can be used with advanced machine learning algorithms to predict self-harm and/or suicide in a 30-day prediction window.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.